New 2021 Forecasts Released

New Data
innovation hub

OpGen (NSDQ:OPGN) is Profiled in this Database

Updated At 23 Jul, 2017

Start Free 7 Day Trial Now
Partial description of this company
Molecular technologies for multi-drug resistant organism (MDRO) testing that can detect more quickly and accurately

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of OpGen (NSDQ:OPGN) plus 4814 other startups.

Start Free 7 Day Trial Now

Learn More About OpGen (NSDQ:OPGN)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png